BrainStorm Cell Therapeutics
BCLI
#10103
Rank
C$10.1 M
Marketcap
$1.55
Share price
14.87%
Change (1 day)
-86.00%
Change (1 year)

Revenue for BrainStorm Cell Therapeutics (BCLI)

Revenue in 2024 (TTM): N/A

.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for BrainStorm Cell Therapeutics from 2009 to 2024

Annual revenue

Year Revenue Change
2024 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A
2013 N/A
2012 N/A
2011 N/A
2010 N/A
2009 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
C$39.76 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
C$25.55 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
C$3.18 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
C$13.38 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.14 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.15 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA